Lee Jason T, White Rodney A
Division of Vascular Surgery H3600, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305-5642, USA.
Surg Clin North Am. 2004 Oct;84(5):1295-318, vi-vii. doi: 10.1016/j.suc.2004.04.012.
The advent and success of endovascular repair of abdominal aneurysms had led to the development of catheter-based techniques to treat thoracic aortic pathology. Such diseases, including thoracic aortic aneurysms, acute and chronic type B dissections,penetrating aortic ulcers, and traumatic aortic transection, challenge surgeons to perform complex operative repairs in high-risk patients. The minimally invasive nature of thoracic endografting may provide an attractive alternative therapy especially in patients deemed unfit for thoracotomy. A worldwide review of thoracic endografting demonstrates encouraging short- and midterm outcomes with significant reductions in morbidity and early mortality.Long-term surveillance will be crucial to discover complications unique to thoracic endovascular interventions and to determine which patients are appropriate candidates for stent-graft therapy.
腹主动脉瘤血管内修复术的出现与成功促使了基于导管技术的发展,用于治疗胸主动脉病变。这类疾病,包括胸主动脉瘤、急慢性B型主动脉夹层、穿透性主动脉溃疡和创伤性主动脉横断,对外科医生提出了挑战,要求他们在高危患者中进行复杂的手术修复。胸主动脉腔内修复术的微创性质可能提供一种有吸引力的替代疗法,特别是对于那些被认为不适合开胸手术的患者。一项全球范围内对胸主动脉腔内修复术的综述显示,其短期和中期结果令人鼓舞,发病率和早期死亡率显著降低。长期监测对于发现胸主动脉血管内介入特有的并发症以及确定哪些患者是支架移植物治疗的合适候选者至关重要。